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Background and aim: The ability of inorganic nitrate and nitrite to convert to nitric oxide (NO), and some of its
properties e.g. regulation of glucose metabolism, vascular homeostasis, and insulin signaling pathway, have recently
raised the hypothesis that inorganic nitrate and nitrite could be potential therapeutic agents in type 2 diabetes. In
this review, we reviewed experimental and clinical studies investigating the effect of nitrate/nitrite administration
on various aspects of type 2 diabetes.
Findings: Studies showed that an altered metabolism of nitrate/nitrite and impaired NO pathway occurs in
diabetes which could contribute to its complications. Some important beneficial properties, including regulation of
glucose homeostasis and insulin signaling pathway, improvement of insulin resistance and vascular function,
hypotensive, hypolipidemic as well as anti-inflammatory and anti-oxidative effects have been observed following
administration of inorganic nitrate/nitrite.
Conclusion: It seems that dietary nitrate/nitrite could be a compensatory fuel for a disrupted nitrate/nitrite/NO
pathway and related disorders in diabetes. Although some beneficial properties of nitrate/nitrite have been
reported by experimental investigations, long-term clinical studies with various doses of inorganic nitrate/nitrite
supplementation, are recommended to confirm these effects.
Keywords: Type 2 diabetes, Insulin resistance, Inorganic nitrate and nitrite, Nitric oxideIntroduction
Inorganic nitrate and nitrite are both naturally occurring
as well as food additive compounds in the human diet.
Vegetables and other plant based foods are the most com-
mon sources of dietary intake of nitrate and contribute up
to 85 % total dietary nitrate intake; green leafy vegetables
including lettuce and spinach, cabbage, rocket, red beet-
root, and radish have higher concentrations of nitrate [1].
Drinking water could also provide considerable amounts
of nitrate; main sources of dietary nitrite are processed
meat and animal food products [1]. Because of the long-
term concerns regarding adverse effects of dietary nitrate
and nitrite such as acute toxicity, e.g. methemoglobinemia,
production of N-nitroso compounds, carcinogenic proper-
ties and potential anti-thyroid effect, strict regulations and
limitations have been legislated for nitrate/nitrite levels of* Correspondence: fzhadaegh@endocrine.ac.ir
5Prevention of Metabolic Disorders Research Center, Research Institute for
Endocrine Sciences, Shahid Beheshti University of Medical Sciences, No. 24,
Sahid-Erabi St, Yemen St, Chamran Exp, 19395-4763 Tehran, Iran
Full list of author information is available at the end of the article
© 2015 Bahadoran et al.; licensee BioMed Cen
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.drinking water and the use of nitrate fertilizer and food
additives [2].
Over the past two decades, data on a possible associ-
ation between high nitrate/nitrite exposure and the risk
of childhood type 1 diabetes is controversial; Virtanen et
al. in 1994 showed that dietary intake of nitrite, but not
nitrate, was positively related to the risk of type 1 diabetes
in Finnish children [3]. Similar associations have also been
reported by others [4–6]; some studies however showed
no significant association [7]. In contrast, recent investiga-
tions have highlighted the beneficial therapeutic effects of
nitrate/nitrite against type 2 diabetes, properties attributed
to the potential effects of nitrate/nitrite on their ability to
convert to nitric oxide [8, 9]. Current evidence reveals that
dietary nitrate/nitrite could restore NO homeostasis and
maintain the steady-state NO levels in pathological condi-
tions related to a disrupted NO pathway [10]. Some evi-
dence also indicates that nitrate/nitrite-rich foods such as
green leafy vegetables play a protective role against type 2
diabetes and cardiovascular disease [11]. It has also been
suggested that high-nitrate content in the diet has atral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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resistance [12], to the best of our knowledge, so far there
is no epidemiological study or clinical investigation to
confirm or reject this hypothesis.
In this review we discuss the possible link between
type 2 diabetes and nitrate/nitrite metabolism and also
the potential effects of these compounds on improvement
of glycemic control and prevention of type 2 diabetes
complications.
The link of type 2 diabetes and nitrate/nitrite/NO
pathway
Nitrate/nitrite/NO pathway
Currently, NO is considered as a biologically active hor-
mone, with several functional properties, including regula-
tion of vascular homeostasis and blood pressure, inhibition
of platelet activation, regulation of energy and lipid metab-
olism as well as mitochondrial biogenesis, and modifica-
tion of various physiological pathways [13, 14]. Impaired
NO metabolism, especially reduced NO production and
NO bioavailability, has been recognized as a risk factor for
development of cardiometabolic disorders, especially vas-
cular dysfunction, cardiovascular disease, chronic kidney
disease, endocrine disorders, insulin resistance, metabolic
syndrome, and type 2 diabetes [15–18].
Both enzymatic and non-enzymatic pathways have been
identified for NO production. Conversion of L-arginine to
NO via three isoforms of NO synthase (NOS) is the clas-
sical, recognized pathway, recent investigations however
show that dietary inorganic nitrate/nitrite could act as a
substrate or backup system for non-enzymatic endogen-
ous generation of NO; studies have also revealed that
administration of nitrate/nitrite is associated with NO-like
bioactivity [19, 20]. The ability of nitrate and nitrite for
production of NO, have highlighted the physiological
importance and novel aspects of the nitrate/nitrite/NO
pathway in health and disease [21].
Impaired nitrate/nitrite/NO pathway and type 2 diabetes
It has been shown that, NO is implicated as a critical
signaling molecule in glucose uptake, and inorganic ni-
trate and nitrite are highlighted as potential therapeutic
agents in insulin resistance and type 2 diabetes [22, 23].
Findings from in vitro and animal investigations have
raised the hypothesis that the nitrate/nitrite/NO pathway
plays a plausible role in glucose homeostasis, insulin se-
cretion, and insulin signaling [24]. A significant associ-
ation between endothelial NO synthase (eNOS) gene
polymorphisms and type 2 diabetes, as well as decreased
eNOS expression in skeletal muscle, and reduced NO
production and bioavailability in insulin resistance states,
clearly underlines the role of NO and its metabolites in
the development of hyper-insulinemia, insulin resistance,
and type 2 diabetes [25–28].On the other hand, growing evidence indicate undesir-
able changes in the metabolism of nitrate/nitrite and
NO under diabetic condition. The impaired NO pathway
in type 2 diabetes has been linked to consequent meta-
bolic disorders and vascular complications [29].
Some well known mechanisms could describe the im-
paired NO pathway in type 2 diabetes; first, chronic hyper-
glycemia, increased oxidative stress and nuclear factor κB
(NF-κB) activation, as well as accumulation of advanced
glycation end products (AGEs) in diabetic condition are
the substantial disruptive factors in the nitrate/nitrite/NO
pathway [30]; second, increased plasma levels of asym-
metric dimethylarginine (ADMA), an endogenous com-
petitive inhibitor of NO synthase, in diabetic condition is
also known as hyperglycemia-induced impairment factor
of NO pathway [31]. Third, decreased NOS activity and
production of NO from L-arginine as well as increased
arginase activity, which leads to decreased L-arginine bio-
availability and NO synthesis via NOS, are other disrupted
pathways in NO homeostasis in diabetic conditions [32];
finally, since activation of NOS is regulated by insulin and
the Akt signaling pathway, impaired insulin secretion and
insulin resistance due to diabetes could affect NO synthe-
sis [33] (Fig. 1).
The altered metabolism of nitrate and nitrite in diabetic
condition
There is no consensus regarding the effect of type 2 dia-
betes on nitrate/nitrite metabolism; both increased and
decreased serum and urinary concentration of nitrate/
nitrite were observed in type 2 diabetic patients (Table 1).
A comparison of 72 type 2 diabetic patients with 60 healthy
controls showed a significant lower plasma level of nitrate
in diabetic patients (24.9 vs. 100 μmol/l) [34]. In a case–
control investigation, a lower nitrate/nitrite concentration
was observed in type 2 diabetic patients without complica-
tions, compared to healthy controls (35 vs. 51 μmol/l); but
the diabetic group with coronary artery disease showed a
higher nitrate/nitrite level (58.9 μmol/l) [35].
Increased serum levels of nitrate/nitrite were also found
in type 2 diabetic patients; one study on microalbuminuric
and normoalbuminuric type 2 diabetic patients, compared
to healthy controls, showed a higher serum and urine
nitrate/nitrite [36]. In this study, serum nitrate/nitrite
concentration was correlated to estimated glomerular
filtration rate (eGFR) values and urinary albumin excretion
[36]. In another cross-sectional study, serum nitrate/nitrite
concentration was significantly higher in subjects with
metabolic syndrome (31.9 vs. 29.8 μmol/l) and type 2
diabetes (34.6 vs. 30.2 μmol/l) compared to controls [37].
Increased serum levels of nitrate/nitrite and enhanced NO
production in diabetes could be a compensatory response
to elevated insulin and oxidative stress; inhibition of



















Fig. 1 The impaired NO pathway in type 2 diabetes. Several mechanisms have been proposed for impaired NO pathway in diabetic condition 1)
Chronic hyperglycemia, increased oxidative stress, NF-κB activation, and accumulation of AGEs 2) Increased plasma levels of ADMA, an endogenous
competitive inhibitor of NO synthase 3) Decreased NOS activity and production of NO from L-arginine, increased arginase activity, decreased
L-arginine bioavailability and NO synthesis via NOS 4) Impaired insulin secretion and insulin resistance. NO; Nitric oxide, NOS; Nitric oxide
synthase, ADMA; Asymmetric dimethylarginine, NF-κB; Nuclear factor κB, AGEs; advanced glycation end products
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status, also increased nitrate/nitrite concentrations [38,
39]. A previous research showed that good glycemic con-
trol in type 2 diabetic patients decreased urinary nitrate/
nitrite fraction and a significant correlation between fast-
ing plasma glucose and the urinary excretion fraction of
nitrate/nitrite was observed (r = 0.12); this observation
could raise the hypothesis that hyperglycemia affects renal
nitrate/nitrite handling [40].
Effects of nitrate/nitrite supplementation on type 2
diabetes and its complications
Effects of dietary nitrate on glucose and insulin
homeostasis: from experimental to human studies
Findings of animal studies that investigated therapeutic
applications of inorganic nitrate or nitrite in diabetic
condition, are presented in Table 2 [41–45]. Intraperito-
neal injection of sodium nitrite in rats, increased pancre-
atic islet blood flow without any effect on total bloodTable 1 Altered metabolism of nitrate/nitrite in type 2 diabetic patie
Author Study population Find
Francesconi, 2001 [40] Type 2 diabetic patients Decr
corre
Kawakatso, 2002 [35] Type 2 diabetic patients with and without
complications, compared with healthy controls
Low
a hig
Apakkan, 2003 [36] Type 2 diabetic patients,
compared with healthy controls
High
Zahedi, 2008 [37] Subjects with type 2 diabetes and metabolic
syndrome, compared with healthy controls
High
and
Shiekh, 2011 [34] Type 2 diabetic patients, compared with
healthy controls
Lowflow of pancreas, and also enhanced plasma insulin con-
centration without any effect on glycemia. In vitro, so-
dium nitrite, dose-dependently in a wide concentration
range (1–100 μm), stimulated insulin secretion from β
cell under basal (5 mM glucose) but not under stimula-
tory (15 mM) conditions; sodium nitrate had no signifi-
cant effects on insulin secretion. In this study, a novel
indirect insulinotropic action of nitrite was also investi-
gated by induction of the NO/guanylyl cyclase/cGMP sig-
naling pathway at basal glucose conditions [41]. A 4-week
administration of 50 mg/l sodium nitrite in diabetic mice
also improved fasting glucose levels and reduced insulin
concentrations; insulin-independent stimulatory effect of
nitrite on glucose transporter type 4 (GLUT4) trans-
location found in cell-culture examination, suggested that
nitrite could improve insulin signaling via restoration of
NO-dependent nitrosation of GLUT4 signaling [42]. Long-
term administration of nitrate (~100 to 300 g nitrate-rich
vegetable, such as spinach, lettuce, or beetroot in humans)nts
ings
eased urinary excretion of nitrate/nitrite after glycemic control; a positive
lation between fasting plasma glucose and urinary nitrate/nitrite
er nitrate/nitrite concentration in diabetic patients without complications;
her nitrate/nitrite level in diabetic group with coronary artery disease
er serum and urine nitrate/nitrite in diabetic patients
er serum nitrate/nitrite concentrations in subjects with type 2 diabetes
metabolic syndrome
er plasma levels of nitrate in diabetic patients
Table 2 The effects of nitrate and nitrite on glucose and insulin homeostasis
Author Animal Treatment Outcomes
Carlstrom, 2010 [41] e-NOS deficient
mice
Addition of NaNO3 drinking
water at a concentration of
85 mg/l for 8–10 weeks
↓ Fasting blood glucose and glycosylated hemoglobin
↓ Pro-insulin to insulin ratio
Improved glucose tolerance test
Nystrom, 2012 [42] Male wistar rats Intraperitoneal injection of
NaNO2 or NaNO3
↑ Plasma nitrite concentration
↑ Pancreatic islet blood flow without any effect on total
pancreas blood flow
↑ Plasma insulin concentration without any effect on glycemia
↑ Insulin secretion from isolated rat islet in vitro under basal
(5 mM glucose) but not under stimulatory (15 mM glucose) conditions
Sodium nitrate had no insulinotropic effects at either glucose
concentration
Ohtake, 2015 [43] KKAy diabetic
mice
Administration of NO2− in
drinking water at a dose of
50 and 150 mg/l for 10 weeks
↓ Glucose level and improve glucose tolerance test at dose of 150 mg/l
Improved insulin resistance, measured by HOMA-IR at both doses
↑ GLUT4 translocation in the cell membrane of skeletal muscle
Jiang, 2015 [44] Db/db diabetic
mice
Administration of 50 mg/l
NaNO2 for 4 weeks
↓ Fasting glucose concentration
↓ Insulin concentration, ↑ insulin sensitivity and insulin signaling
↑ GLUT4 translocation in skeletal muscle and adipose tissue in vitro
at a dose of 10 and 100 μM
Khalifi, 2015 [45] Streptozotocin-induced
diabetic rats
Administration of NaNO3 in
drinking water at a dose
of 100 mg/l for 8 weeks
Restored serum nitrate/nitrite to normal values
Improved glucose tolerance
NaNo3, Sodium nitrate; NaNo2, sodium nitrite
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type; in this study acute doses of inorganic nitrate in-
creased circulating bioactive nitrogen oxides, and chronic
administration of nitrate improved glucose homeostasis
and decreased pro-insulin/insulin ratios compared to non-
treated eNOS-deficient mice [46].
Figure 2 illustrates the main mechanisms that describe
therapeutic effects of nitrate/nitrite on glucose homeostasis
and insulin signaling. In brief, this figure shows that nitrate/
nitrite could increase insulin secretion by increase pancre-
atic islet blood flow and activation of guanylyl cyclase and
the cGMP pathway; nitrate/nitrite also improve insulin re-
sistance and glucose uptake by increase gene expression of
GLUT4. Moreover, nitrate/nitrite increase nitrosation and
insulin-independent translocation of GLUT4 and also in-
crease glucose uptake by skeletal muscle and adipose tissue.
Nitrate also inhibits the production of reactive oxygen spe-
cies (ROS) in adipoceytes and dephosphorylation activity of
protein-tyrosine phosphatase 1B, thereby facilitating phos-
phorylation of insulin receptor substrate and subsequently
GLUT4 translocation and glucose uptake [43].
Beyond in vitro and animal investigations, there is a
growing interest for use of clinical trials to determine
possible effects of nitrate-rich foods on glycemic control
and insulin resistance. However, some beneficial effects
were observed following nitrate/nitrite supplementation in
humans, but a short intervention-period was an important
limitation to confirmation of the expected properties.Two-week supplementation with high-nitrate beetroot
juice (~250 mg nitrate) in type 2 diabetic patients
compared to depleted-nitrate beetroot juice (~0.002 mg
nitrate), had no significant effect on insulin resistance and
whole body glucose disposal, but it did improve simple re-
action time as a measure of cognitive function [47, 48]. In
this study, median serum concentrations of nitrate (150 vs.
31 μmol/, P < 0.001) and nitrite (390 vs. 232 nmol/l, P <
0.001) were significantly higher in the intervention com-
pared to placebo groups [40]. In a randomized cross-over
clinical trial of type 2 diabetic patients, acute intra-femoral
infusion of sodium nitroprusside (a NO donor compound)
compared to verapamil, resulted in greater glucose uptake
independent of plasma insulin concentration [46], but
infusion of sodium nitroprusside or oral supplementation
with nitrate (as isosorbide mononitrate or pentaerythritol
tetranitrate) in healthy men had no effect on plasma
glucose or insulin levels [49]. Moreover, consumption of
beetroot juice had no considerable effect on postprandial
plasma glucose and insulin levels in overweight and obese
men [50].
Effects of nitrate/nitrite on vascular function and blood
pressure
It is well known that impaired vascular function, subse-
quent elevated blood pressure and vascular disease are
important undesirable complications of developing insulin
resistance and type 2 diabetes; hence therapeutic approach
Fig. 2 Proposed mechanisms of effects of nitrate/nitrite on glucose homeostasis and insulin signaling. Nitrate/nitrite increase insulin secretion
by increasing pancreatic islet blood flow (1) and activation of guanylyl cyclase and cGMP pathway (2). Nitrate/nitrite induce NO production and
improve insulin resistance and glucose uptake by increasing gene expression of GLUT4 (3). Nitrate/nitrite increase nitrosation and insulin-independent
translocation of GLUT4 and increase glucose uptake by skeletal muscle and adipose tissue (4). Nitrate/nitrite also inhibits production of reactive oxygen
species (ROS) in adipoceytes and dephosphorylation activity of protein-tyrosine phosphatase 1B and then facilitate phosphorylation of insulin receptor
substrate and subsequently GLUT4 translocation and glucose uptake (5). ROS; Reactive oxygen species, IRS; Insulin receptor substrate, PI3K;
Phosphatydal inositol 3 kinase, PKB; Protein kinase B, GLUT4; Glucose transporter 4, NO; Nitric oxide
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ment of type 2 diabetic patients [51, 52].
The potential property of inorganic nitrate and nitrite
to convert to NO, a key regulator of vascular homeosta-
sis and a natural vasodilator, has highlighted these an-
ions as therapeutic options in vascular abnormalities and
hypertension states [53]. In animal models, administra-
tion of sodium nitrate enhanced revascularization, in-
creased migration of bone marrow-derived cells to the
ischemic-site, and attenuated apoptosis of regenerative
myoblasts in ischemic tissue [54]. Supplementation with
sodium nitrate in eNOS-deficient mice with features of
metabolic syndrome reduced blood pressure [41]; a simi-
lar effect was also observed following treatment with inor-
ganic nitrate in hypertensive and eNOS deficient rat,
against hypertension and myocardial ischemia-reperfusion
injury [20, 55]; these findings indicate the compensatory
effects of exogenous nitrate for a disrupted nitrate/nitrite/
NO pathway and related disorders in pathological condi-
tions. Administration of sodium nitrite in high-fat induced
hypercholesterolemic rat models had anti-inflammatory
effects and inhibits the leukocyte adhesion and emigration
and prevented the vascular dysfunction [56].
Findings from clinical studies also suggest that inorganic
nitrate could be considered as a supplementary treatment
in type 2 diabetes. Dietary supplementation with sodium
nitrate at a dose of 150 μmol/kg body weight (~300 g
spinach) could improve endothelial dysfunction andvascular stiffness in subjects with moderately increased
cardiovascular risk [57]. Other cardiovascular protective
effects including anti-platelet activity, hypolipidemic and
anti-inflammatory effects, and improved blood flow in
hypoxic and ischemic tissue have also been reported
following nitrate/nitrite supplementation [53, 58, 59].
Improvement of endothelial dysfunction and a blood
pressure lowering effect of nitrate have been observed in
several clinical investigations; a recent meta-analysis
reported considerable decrease in systolic (−4.4 mm Hg;
95 % CI = −5.9, −2.8; P < 0.001) and diastolic blood pres-
sure (−1.1 mm Hg; 95 % CI = −2.2, 0.1; P = 0.06) following
supplementation with inorganic nitrate and high-nitrate
beetroot juice [60]. Findings from another meta-analysis
also report the beneficial effects of inorganic nitrate
supplementation on vascular function [61], effects which
have not yet been confirmed in diabetic patients [47]. In a
double-blind, randomized, placebo-controlled crossover
trial, 2-weeks supplementation with 250 ml/d beetroot juice
(7.5 mmol nitrate/d) or 250 ml/d nitrate-depleted beetroot
juice (0.002 mmol nitrate/d), increased plasma concentra-
tion of nitrite and nitrate, but no significant changes was
observed in systolic and diastolic blood pressures, or in
macro- or micro-vascular endothelial function [60].
Data shows that impaired metabolic pathways in dia-
betes could lead to diminished NO production and bio-
availability, inactivated NO and impaired eNOS activity and
endothelium-dependent vasodilatation [30, 62], indicating
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dietary nitrate supplementation observed in healthy sub-
jects, would be mild in diabetic patients. It should be
mentioned here that supplementation with any of the bio-
active food components has not yet been confirmed for
use in people with diabetes [63].
Effects of nitrate/nitrite on energy homeostasis and adipose
tissue metabolism
A significant association of serum NO and its metabo-
lites with visceral fat and anthropometric measures, ob-
served in a previous cross-sectional study [64] suggested
that nitrate/nitrite/NO pathway may be important in en-
ergy homeostasis and adipose tissue metabolism, but the
experimental effects of inorganic nitrate/nitrite in this field
is still a controversial less documented issue. Although
some animal investigations reported reduced weight gain
and visceral fat accumulation following nitrate/nitrite
administration [41], other studies observed no significant
changes in usual food intake or the trend of weight gain at
various doses of nitrate and nitrite. Moreover, changes in
adipose tissue morphology including decreased adipocyte
size were observed after administration of sodium nitrite
at doses of 50 and 150 mg/l in drinking water of diabetic
rat models [43]. Evidence shows that inorganic nitrate
enhances expression of thermogenic genes in both brown
and white adipose tissue, increases oxygen consumption
and β-oxidation of fatty acids, promotes the browning of
white adipose tissue and induces anti-obesity effects [65].
More interestingly, it has been demonstrated that the
nitrate/nitrite/NO pathway interacts with mitochon-
drion biogenesis and metabolism; inorganic nitrate could
improve oxidative phosphorylation efficiency (P/O ratio),
thermodynamic efficiency, and reduce the expression ofTable 3 Beneficial effects of nitrate/nitrite administration on type 2
Author Animal Treatment
Ohtake, 2007 [67] Streptozotocin-induced
diabetic male rats
Administration of n
in drinking water fo
Carlstrom, 2011 [68] Sprague–Dawley rats subjected
to unilateral nephrectomy
and chronic high-salt diet
Administration of n
doses of 0.14 and 1
NaNO3/kg diet for 1
NaNo3; Sodium nitrate, NOS; Nitric oxide synthaseATP/ADP translocase, a protein involved in proton con-
ductance, of the respiratory chain in mitochondria [66].Effects of nitrate/nitrite on lipid metabolism
The favorable effects on lipid and lipoprotein metabol-
ism are other potential properties of inorganic nitrate/
nitrite. Administration of sodium nitrate in diabetic rat
models significantly decreased serum triglycerides, total
cholesterol and LDL-C and increased HDL-C levels [45].
A substantial decrease in TG levels was also observed
in e-NOS deficient mice after treatment with inorganic
nitrate [35]. In humans, 30-day supplementation with
dietary nitrate in subjects at risk of cardiovascular dis-
ease normalized TG concentration [29].Other beneficial effects of nitrate/nitrite on diabetes
complications
There is growing evidence that nitrate/nitrite supplemen-
tation, at a moderate dose (comparable with the normal
human diet, provided 100–300 g of nitrate-rich vegetables
via daily consumption), has interesting physiological func-
tions which could be beneficial in the prevention of diabetes-
related complications. Anti-inflammatory and anti-oxidative
effects of nitrate/nitrite as well as preventive properties
against micro- and macro-vascular disorders and renal in-
jury are important of these benefits [67]. Treatment with
inorganic nitrate could attenuate reduced levels of total
antioxidant capacity and catalase activity as well as in-
crease the level of pro-inflammatory cytokines in diabetic
condition [45, 67, 68]. Table 3 illustrates the potential
beneficial effects of nitrate/nitrite supplementation against
renal dysfunction in diabetic and other similar patho-




↓ Serum malondialdehyde concentrations
↑ Nitrite levels in the kidney
Improvement in glomerular injury parameters including
urinary protein and albumin excretion, histopathological





Improvement of histological renal injury, cardiac
hypertrophy and fibrosis
Restored tissue levels of bioactive nitrogen oxides
↓ Plasma malondialdehyde concentration
↓Urinary F2-isoprostanes and 8-hydroxy-2-deoxyguanosine
Attenuates increased plasma and urinary levels of
dimethylarginine (an endogenous NOS inhibitor)
↑ Serum L-arginine levels
Bahadoran et al. Nutrition & Metabolism  (2015) 12:16 Page 7 of 9Potential side effects of inorganic nitrate/nitrite
With respect to the reported adverse effects of nitrate/
nitrite, including both acute and chronic-subclinical tox-
icity, and also given the large number of ongoing researches
in this field, it is essential to clarify the pharmacokinetics
and potential side effects of nitrate/nitrite. Considering the
increasing concern regarding high-doses of nitrite supple-
mentation, it appears that the use of nitrate from natural
sources is less hazardous [69].
Greenway et al. in a randomized crossover study of 12
diabetic patients, assessed the effects of 80 mg sodium
nitrite with both immediate release and enteric-coated
formulations on methemoglobin, sulfhemoglobin, blood
pressure, pulse rate, complete blood count, chemistry
panel, reported a good tolerance without any adverse
events [70]. In another study, Mohler et al. also reported
no adverse effect following supplementation with two
doses of 40 and 80 mg sodium nitrite in patients with
diabetes and peripheral artery disease [71]. However, the
potential adverse effects of nitrate to generate peroxynitrite
and reactive nitrogen intermediates, has been a main con-
cern for a long time; more recent studies however reported
no significant increase in the nitration reaction following
supplementation of inorganic nitrate [66].
Conclusion
Findings from in vitro and animal studies indicate that
inorganic nitrate/nitrite could be considered as an alter-
native source of endogenous NO which could enhance
the insulin signaling pathway, glucose uptake and attenu-
ate insulin resistance and diabetes complications. Dietary
nitrate/nitrite could also attenuate other disrupted NO-
dependent pathways including vascular function, regula-
tion of blood pressure, mitochondrial biogenesis and
energy homeostasis as well as adipose tissue metabol-
ism, lipid and lipoprotein metabolism, in diabetes. There
are many reasons to support the hypothesis whether a
nitrate/nitrite rich diets provides an effective nutritional
strategy for management of type 2 diabetes and preven-
tion of complications. Long-term interventional studies
with various doses and food sources of inorganic nitrate/
nitrite in human should be performed to confirm thera-
peutic properties and detect potential unwanted and ad-
verse effects of these compounds.
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